Literature DB >> 22665809

Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children.

Ivo Mueller1, Sonja Schoepflin, Thomas A Smith, Kathryn L Benton, Michael T Bretscher, Enmoore Lin, Benson Kiniboro, Peter A Zimmerman, Terence P Speed, Peter Siba, Ingrid Felger.   

Abstract

Genotyping Plasmodium falciparum parasites in longitudinal studies provides a robust approach to estimating force of infection (FOI) in the presence of superinfections. The molecular parameter (mol)FOI, defined as the number of new P. falciparum clones acquired over time, describes basic malaria epidemiology and is suitable for measuring outcomes of interventions. This study was designed to test whether (mol)FOI influenced the risk of clinical malaria episodes and how far (mol)FOI reflected environmental determinants of transmission, such as seasonality and small-scale geographical variation or effects of insecticide-treated nets (ITNs). Two hundred sixty-four children 1-3 y of age from Papua New Guinea were followed over 16 mo. Individual parasite clones were tracked longitudinally by genotyping. On average, children acquired 5.9 (SD 9.6) new P. falciparum infections per child per y. (mol)FOI showed a pronounced seasonality, was strongly reduced in children using ITNs (incidence rate ratio, 0.49; 95% confidence interval, [0.38, 0.61]), increased with age, and significantly varied within villages (P = 0.001). The acquisition of new parasite clones was the major factor determining the risk of clinical illness (incidence rate ratio, 2.12; 95% confidence interval, [1.93, 2.31]). Adjusting for individual differences in (mol)FOI completely explained spatial variation, age trends, and the effect of ITN use. This study highlights the suitability of (mol)FOI as a measure of individual exposure and its central role in malaria epidemiology. It has substantial advantages over entomological measures in studies of transmission patterns, and could be used in analyses of host variation in susceptibility, in field efficacy trials of novel interventions or vaccines, and for evaluating intervention effects.

Entities:  

Mesh:

Year:  2012        PMID: 22665809      PMCID: PMC3382533          DOI: 10.1073/pnas.1200841109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Age and seasonal variation in the transition rates and detectability of Plasmodium falciparum malaria.

Authors:  W Sama; S Owusu-Agyei; I Felger; K Dietz; T Smith
Journal:  Parasitology       Date:  2006-01       Impact factor: 3.234

2.  Multiple Plasmodium falciparum infections in Tanzanian infants.

Authors:  I Felger; T Smith; D Edoh; A Kitua; P Alonso; M Tanner; H P Beck
Journal:  Trans R Soc Trop Med Hyg       Date:  1999-02       Impact factor: 2.184

3.  Heterogeneities in the transmission of infectious agents: implications for the design of control programs.

Authors:  M E Woolhouse; C Dye; J F Etard; T Smith; J D Charlwood; G P Garnett; P Hagan; J L Hii; P D Ndhlovu; R J Quinnell; C H Watts; S K Chandiwana; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea.

Authors:  J L Hii; T Smith; A Mai; S Mellor; D Lewis; N Alexander; M P Alpers
Journal:  J Med Entomol       Date:  1997-03       Impact factor: 2.278

5.  Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria. Part 4. Effects on incidence of malaria infection.

Authors:  F H Msuya; C F Curtis
Journal:  Acta Trop       Date:  1991-08       Impact factor: 3.112

6.  Mating patterns in malaria parasite populations of Papua New Guinea.

Authors:  R E Paul; M J Packer; M Walmsley; M Lagog; L C Ranford-Cartwright; R Paru; K P Day
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

7.  Vector-related case-control study of severe malaria in Kilifi District, Kenya.

Authors:  C N Mbogo; E W Kabiru; G E Glass; D Forster; R W Snow; C P Khamala; J H Ouma; J I Githure; K Marsh; J C Beier
Journal:  Am J Trop Med Hyg       Date:  1999-05       Impact factor: 2.345

Review 8.  Molecular monitoring in malaria vaccine trials.

Authors:  Ingrid Felger; Blaise Genton; Tom Smith; Marcel Tanner; Hans Peter Beck
Journal:  Trends Parasitol       Date:  2003-02

9.  Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya.

Authors:  Philip Bejon; Thomas N Williams; Anne Liljander; Abdisalan M Noor; Juliana Wambua; Edna Ogada; Ally Olotu; Faith H A Osier; Simon I Hay; Anna Färnert; Kevin Marsh
Journal:  PLoS Med       Date:  2010-07-06       Impact factor: 11.069

10.  Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2).

Authors:  Anne Liljander; Lisa Wiklund; Nicole Falk; Margaret Kweku; Andreas Mårtensson; Ingrid Felger; Anna Färnert
Journal:  Malar J       Date:  2009-04-23       Impact factor: 2.979

View more
  68 in total

1.  Joint Modeling of Mixed Plasmodium Species Infections Using a Bivariate Poisson Lognormal Model.

Authors:  Kathryn L Colborn; Ivo Mueller; Terence P Speed
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

Review 2.  Update on the burden of Campylobacter in developing countries.

Authors:  James A Platts-Mills; Margaret Kosek
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

Review 3.  Uncovering the transmission dynamics of Plasmodium vivax using population genetics.

Authors:  Alyssa E Barry; Andreea Waltmann; Cristian Koepfli; Celine Barnadas; Ivo Mueller
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

4.  Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.

Authors:  Jo-Anne Chan; Danielle I Stanisic; Michael F Duffy; Leanne J Robinson; Enmoore Lin; James W Kazura; Christopher L King; Peter M Siba; Freya Ji Fowkes; Ivo Mueller; James G Beeson
Journal:  Eur J Immunol       Date:  2017-09-13       Impact factor: 5.532

Review 5.  Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics.

Authors:  Lucy S Tusting; Teun Bousema; David L Smith; Chris Drakeley
Journal:  Adv Parasitol       Date:  2014       Impact factor: 3.870

6.  Clinical Implications of Asymptomatic Plasmodium falciparum Infections in Malawi.

Authors:  Andrea G Buchwald; Alick Sixpence; Mabvuto Chimenya; Milius Damson; John D Sorkin; Mark L Wilson; Karl Seydel; Sarah Hochman; Don P Mathanga; Terrie E Taylor; Miriam K Laufer
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

7.  Antibodies to Intercellular Adhesion Molecule 1-Binding Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLβ Are Biomarkers of Protective Immunity to Malaria in a Cohort of Young Children from Papua New Guinea.

Authors:  Sofonias K Tessema; Digjaya Utama; Olga Chesnokov; Anthony N Hodder; Clara S Lin; G L Abby Harrison; Jakob S Jespersen; Bent Petersen; Livingstone Tavul; Peter Siba; Dominic Kwiatkowski; Thomas Lavstsen; Diana S Hansen; Andrew V Oleinikov; Ivo Mueller; Alyssa E Barry
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

Review 8.  Mobile phones and malaria: modeling human and parasite travel.

Authors:  Caroline O Buckee; Amy Wesolowski; Nathan N Eagle; Elsa Hansen; Robert W Snow
Journal:  Travel Med Infect Dis       Date:  2013-03-09       Impact factor: 6.211

9.  Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.

Authors:  Danica A Helb; Kevin K A Tetteh; Philip L Felgner; Jeff Skinner; Alan Hubbard; Emmanuel Arinaitwe; Harriet Mayanja-Kizza; Isaac Ssewanyana; Moses R Kamya; James G Beeson; Jordan Tappero; David L Smith; Peter D Crompton; Philip J Rosenthal; Grant Dorsey; Christopher J Drakeley; Bryan Greenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 10.  Ivermectin: a complimentary weapon against the spread of malaria?

Authors:  Haoues Alout; Brian D Foy
Journal:  Expert Rev Anti Infect Ther       Date:  2016-12-29       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.